Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne H Cross

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Journal of Neuroimmunology|August 5, 2022
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesisFrancesca Aloisi, Anne H Cross
The New England Journal of Medicine|July 13, 2012
Antibodies to potassium channels in multiple sclerosisAnne H Cross, Emmanuelle Waubant
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Can CSF biomarkers predict future MS disease activity and severity?Roberta Magliozzi, Anne H Cross
Biochimica Et Biophysica Acta|August 3, 2010
MS and the B cell controversyAnne H Cross, Emmanuelle Waubant
International Immunology|December 24, 2005
Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitisJennifer L Stark, Anne H Cross
JAMA Neurology|May 15, 2023
Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?Jeffrey A Cohen, Anne H Cross
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2021
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - NoAnne H Cross, Robert T Naismith
Neurology|September 21, 2014
Antisense therapy: potential tool to reduce activity in MS via protein expression inhibitionRobert T Naismith, Anne H Cross
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2014
Dimethyl fumarate associated lymphopenia in clinical practiceErin E Longbrake, Anne H Cross
Neurology|May 29, 2003
Neurologic manifestations of celiac disease: proven, or just a gut feeling?Anne H Cross, Paul T Golumbek
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Journal of Neuroimmunology|August 5, 2022
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesisFrancesca Aloisi, Anne H Cross
The New England Journal of Medicine|July 13, 2012
Antibodies to potassium channels in multiple sclerosisAnne H Cross, Emmanuelle Waubant
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Can CSF biomarkers predict future MS disease activity and severity?Roberta Magliozzi, Anne H Cross
Biochimica Et Biophysica Acta|August 3, 2010
MS and the B cell controversyAnne H Cross, Emmanuelle Waubant
International Immunology|December 24, 2005
Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitisJennifer L Stark, Anne H Cross
JAMA Neurology|May 15, 2023
Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?Jeffrey A Cohen, Anne H Cross
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 20, 2021
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - NoAnne H Cross, Robert T Naismith
Neurology|September 21, 2014
Antisense therapy: potential tool to reduce activity in MS via protein expression inhibitionRobert T Naismith, Anne H Cross
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2014
Dimethyl fumarate associated lymphopenia in clinical practiceErin E Longbrake, Anne H Cross
Neurology|May 29, 2003
Neurologic manifestations of celiac disease: proven, or just a gut feeling?Anne H Cross, Paul T Golumbek
Pageof 20